Multiple sclerosis: molecular pathogenesis and therapeutic intervention.

Area of Science:

• Immunology
• Neuroscience
• Biotechnology

Background:

• Multiple sclerosis (MS) is a chronic, immune-mediated central nervous system disorder.
• Current MS therapies struggle to halt progressive neurological disability.
• Novel strategies are crucial for treating MS effectively.

Purpose of the Study:

• To review the current landscape of antigen-specific immunotherapy for multiple sclerosis.
• To examine the successes, limitations, and translational challenges of antigen-specific approaches.
• To propose future directions for developing transformative MS therapies.

Main Methods:

• Comprehensive review of preclinical studies and clinical trials on antigen-specific immunotherapy modalities.
• Analysis of diverse approaches including peptide-based vaccines and nanoparticle platforms.
• Integration of insights from immunology, biotechnology, and translational medicine.

Main Results:

• Antigen-specific immunotherapy aims to restore immune tolerance to myelin antigens.
• This approach offers targeted modulation of immune responses with potentially fewer off-target effects.
• Various modalities have been explored to achieve durable tolerance in MS.

Conclusions:

• Antigen-specific immunotherapy holds promise as a transformative therapeutic strategy for multiple sclerosis.
• Overcoming translational challenges is key to realizing the potential of these targeted approaches.
• Further research integrating multiple disciplines is needed to advance MS treatment.